KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Net Income: 2009-2024

Historic Net Income for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to -$69.9 million.

  • Arbutus Biopharma's Net Income rose 60.81% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.3 million, marking a year-over-year increase of 44.89%. This contributed to the annual value of -$69.9 million for FY2024, which is 4.02% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Net Income of -$69.9 million as of FY2024, which was up 4.02% from -$72.8 million recorded in FY2023.
  • Arbutus Biopharma's 5-year Net Income high stood at -$63.7 million for FY2020, and its period low was -$76.2 million during FY2021.
  • For the 3-year period, Arbutus Biopharma's Net Income averaged around -$70.7 million, with its median value being -$69.9 million (2024).
  • As far as peak fluctuations go, Arbutus Biopharma's Net Income soared by 58.53% in 2020, and later decreased by 19.61% in 2021.
  • Over the past 5 years, Arbutus Biopharma's Net Income (Yearly) stood at -$63.7 million in 2020, then declined by 19.61% to -$76.2 million in 2021, then grew by 8.91% to -$69.5 million in 2022, then decreased by 4.89% to -$72.8 million in 2023, then increased by 4.02% to -$69.9 million in 2024.